Literature DB >> 23774967

[Sebaceous gland tumor with a rare gene mutation within a tumor syndrome: Muir-Torre syndrome].

E Voigt1, F Sommer, K D Geiger, L E Pillunat.   

Abstract

Muir-Torre syndrome is a rare autosomal dominant subtype of hereditary nonpolyposis colorectal carcinoma and is characterized by the simultaneous occurrence of sebaceous gland neoplasms with visceral and urogenital malignancies. This article describes the case of a 72-year-old patient who was referred to our clinic for removal of an upper eyelid tumor, showing the course from the clinical findings to the rare diagnosis of Muir-Torre syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 23774967     DOI: 10.1007/s00347-013-2879-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  Familial endometrial cancer in female carriers of MSH6 germline mutations.

Authors:  J Wijnen; W de Leeuw; H Vasen; H van der Klift; P Møller; A Stormorken; H Meijers-Heijboer; D Lindhout; F Menko; S Vossen; G Möslein; C Tops; A Bröcker-Vriends; Y Wu; R Hofstra; R Sijmons; C Cornelisse; H Morreau; R Fodde
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

2.  Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient With Muir-Torre syndrome.

Authors:  Zarry Tavakkol; Jesse J Keller; Paul S Furmanczyk; Robin L Bennett; Andy J Chien
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

3.  MSH6 mutation in Muir-Torre syndrome: could this be a rare finding?

Authors:  E Mangold; N Rahner; N Friedrichs; R Buettner; C Pagenstecher; S Aretz; W Friedl; T Ruzicka; P Propping; A Rütten; R Kruse
Journal:  Br J Dermatol       Date:  2007-01       Impact factor: 9.302

4.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Authors:  Angela Arnold; Stewart Payne; Samantha Fisher; Diane Fricker; Judith Soloway; Susan M White; Marco Novelli; Kylie MacDonald; James Mackay; Richard Groves; Natalie Canham
Journal:  Fam Cancer       Date:  2007-02-24       Impact factor: 2.375

5.  MSH6 mutation in a family affected by Muir-Torre syndrome.

Authors:  Denisa Kacerovska; Katerina Cerna; Petr Martinek; Petr Grossmann; Michal Michal; Jan Ricar; Dmitry V Kazakov
Journal:  Am J Dermatopathol       Date:  2012-08       Impact factor: 1.533

6.  [Female patient with Muir-Torre syndrome].

Authors:  N Negraszus; K Jöhrens; E Bertelmann
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

7.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

8.  Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.

Authors:  T Graefe; U Wollina; H Schulz; W Burgdorf
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 9.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.

Authors:  Larissa A Meyer; Russell R Broaddus; Karen H Lu
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

10.  Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.

Authors:  Jens Plaschke; Christoph Engel; Stefan Krüger; Elke Holinski-Feder; Constanze Pagenstecher; Elisabeth Mangold; Gabriela Moeslein; Karsten Schulmann; Johannes Gebert; Magnus von Knebel Doeberitz; Josef Rüschoff; Markus Loeffler; Hans K Schackert
Journal:  J Clin Oncol       Date:  2004-10-13       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.